- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
教学课件课件PPT医学培训课件教育资源教材讲义
Since 1999, data on antibiotic resistance in Europe are available from the European Antimicrobial Resistance Surveillance System (EARSS). This surveillance has repeatedly shown large inter-country variations in the percentage of bacteria resistant to antibiotics. In 2007, the percentage of – for example – methicillin-resistant Staphylococcus aureus (MRSA) – the most common single resistant bacteria responsible for healthcare-associated infections varies from less than 1% (in 2 Member States) to more than 25% (in 10 Member States). This means that when a doctor in these countries is treating a patient whose blood is infected with Staphylococcus aureus, there is a one in four probability (or more) that the bacteria will not respond to the antibiotic commonly given to treat this type of infection. Comparison over time with data from 2002 – the year following adoption of Council Recommendation (2002/77/EC) – the antimicrobial resistance situation has not changed much. For MRSA, it has actually become worse in many countries – this includes including countries that traditionally had low resistance. Data from the European dedicated surveillance system on antimicrobial consumption ESAC show a 3-fold difference between the Member State with the highest antibiotic consumption and the country with the lowest antibiotic consumption. ecdc.europa.eu Professor Karl Ekdahl, Helsinki, 9 December European Centre for Disease Prevention and Control Combating Communicable Diseases in Northern Europe Expanded Europe – the Five Freedoms in the EU 1. Free Movement of People* Free Movement of Services* Free Movement of Goods* 4. Free Movement of Monies* 5. Free Movement of Micro-organisms * Adapted from Summary of Legislation - Internal Market /scadplus/leg/en/s70000.htm What is ECDC? An independent agency, named the European Centre for Disease Prevention and Control (Regulation 851/2004) A European Union Agency which: Is a member of the European Union (EU) family Covers EU 2
您可能关注的文档
- 卡介苗能治疗癌症的作用机理案例实例.ppt
- 卡文杯总结概括.ppt
- 开课计划录入操作指南资料汇总.ppt
- 开颅术后的重症监护幻灯片课件.ppt
- 开学第一天 教学 语文A版二上课件教程文件.ppt
- 看病例读片子辩疾病总结概括.ppt
- 看不见的风 教学 语文A版二上课件教学教程.ppt
- 康复医师教学基地申报讲解说明.ppt
- 康复医学精品课程-冠心病康复教程文件.ppt
- 抗 生 素 和 人 类 健 康方案说明.ppt
- 抗生素(英文精品) Diffusion in nanostructures Role of interaction potentials教学教程.ppt
- 抗生素(英文精品) Drug Action in the Cell教程文件.ppt
- 抗生素(英文精品) Emergence of Extended Spectrum Beta-lactamases (ESBLs) in Sudan讲解说明.ppt
- 抗生素(英文精品) Food additives analysis幻灯片课件.ppt
- 抗生素(英文精品) Infection in acute pancreatitis方案说明.ppt
- 抗生素(英文精品) Infectious Diseases Resistant Organisms总结概括.ppt
- 抗生素(英文精品) Information on Staphlococcus aureus and Resistant Staphlococcus aureus (MRSA)资料汇总.ppt
- 抗生素(英文精品) Is Resistance Futile幻灯片课件.ppt
- 抗生素(英文精品) Leaching of a Veterinary Antibiotic through Soil Columns方案说明.ppt
- 抗生素(英文精品) Lives Saved Tool (LIST) What is modeled方案说明.ppt
最近下载
- 某公司完整版审批权限表.doc VIP
- 2025浙江杭州青山湖科技城投资集团有限公司下属子公司招聘11人考试模拟试题及答案解析.docx VIP
- 马自达-马自达6阿特兹-产品使用说明书-马自达6阿特兹 2.5L蓝天尊崇版-CA7250ATE4-MAZDA6ATENZA用户手册.pdf VIP
- 泡泡玛特简介.pptx VIP
- 马勒第一交响曲(钢琴版)第3乐章.pdf VIP
- 西门子断路器3WL操作手册.pdf
- 《产业园区投建营数字化平台建设指南》.pdf VIP
- 00015 《英语(二)》高频 100 题.doc VIP
- 2024年一建管理真题完整.docx VIP
- 中医面诊知识培训课件.pptx VIP
文档评论(0)